NDC 66689-047-01 - Potassium Chloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 66689-047
- Requested NDC
- 66689-047-01
- Package NDCs from labels
- 66689-047-01, 66689-047-50, 66689-047-99, 66689-047-30, 66689-047-80
- Manufacturer
- VistaPharm, LLC
- Effective date
- 2024-05-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Potassium Chloride - VistaPharm, LLC | VistaPharm, LLC | 2024-05-09 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 66689-047-01 | ML - Milliliter | 66689-047 | bb1736ab-dff9-425e-96b9-0b14a2b2da91 | 1 | 2016-03-04 |
| 66689-047-30 | ML - Milliliter | 66689-047 | 9bfe89f8-8f34-4cb6-b8f3-2a4a4e298b60 | 1 | 2017-07-07 |
| 66689-047-50 | ML - Milliliter | 66689-047 | dcc36d0c-834f-4de0-b82b-51b62fc79b12 | 1 | 2016-03-04 |
| 66689-047-80 | ML - Milliliter | 66689-047 | 729fbfda-64b8-4c88-ae26-404d0df09f64 | 1 | 2017-07-07 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| OHM Mucus Relief | ANTIMONIUM CRUDUM, ANTIMONIUM TARTARICUM, CHELIDONIUM MAJUS, FERRUM PHOSPHORICUM, KALI CARBOONICUM, KALI MURIATICUM, KALI SULPHURICUM, MARRUBIUM VULGARE. | OHM PHARMA INC. | f13bff50-7087-46dc-a958-b460a2af6283 | 2021-01-11 | Warnings | 660YQ98I10 |
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | Lupin Pharmaceuticals,Inc. | 28c49165-d8c9-443a-b000-953b8e1ec55c | 2020-11-20 | Warnings, Adverse reactions | 314182 312515 660YQ98I10 |
| Lactated Ringers | SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, AND CALCIUM CHLORIDE | Asclemed USA, Inc. | afac6cc5-1ced-4639-b6f6-86f40ef5c30e | 2020-10-29 | Warnings, Adverse reactions | 660YQ98I10 |
| InterSol | PLATELET ADDITIVE 3 | Fenwal, Inc. | a00c4a93-cde2-4753-81f7-0d6fee9fb690 | 2020-10-20 | Warnings, Adverse reactions | B22547B95K |
| POTASSIUM CHLORIDE IN DEXTROSE | DEXTROSE AND POTASSIUM CHLORIDE | B. Braun Medical Inc. | e5bbb3e1-ab50-4ec7-a2b4-ce4091712e23 | 2020-07-31 | Warnings, Adverse reactions | 660YQ98I10 |
| Bach Original Flower Remedies | WATER | Nelson Bach USA Limited | 09c76050-42c5-4403-865c-a1f6f668d9c0 | 2020-06-15 | Warnings | 059QF0KO0R |
| Cardioplegic | CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, POTASSIUM CHLORIDE AND SODIUM CHLORIDE | Baxter Healthcare Corporation | 1fd50ce5-2799-4c26-81da-02cf0578dd9e | 2020-06-11 | Warnings, Adverse reactions | 660YQ98I10 |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | ee831456-5962-4d5e-ad0c-69ab85860453 | 2020-06-03 | XF417D3PSL B22547B95K | |
| LACTATED RINGERS AND DEXTROSE | SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, AND DEXTROSE MONOHYDRATE | HF Acquisition Co LLC, DBA HealthFirst | a62cf623-9b8a-37e0-e053-2995a90add5b | 2020-05-21 | Warnings, Adverse reactions | 660YQ98I10 |
| Isolyte S | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE | B. Braun Medical Inc. | 7e8fe27f-ff82-48c1-9bf6-3c589c8e985d | 2020-05-14 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Genus Lifesciences Inc. | 23d818e7-c076-40de-8dc1-0b51ba4be96a | 2020-04-28 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Lupin Pharmaceuticals,Inc. | 1bbacdbb-91fa-4897-a00c-1b293de27b83 | 2020-04-27 | Warnings, Adverse reactions | 660YQ98I10 |
| Potassium Chloride | POTASSIUM CHLORIDE | Mylan Pharmaceuticals Inc. | c64ed4c0-1e27-42b3-9625-fb4e0d31e271 | 2020-04-15 | Warnings, Adverse reactions | 660YQ98I10 |
| Dextrose and Electrolyte No. 48 | SODIUM LACTATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, MONOBASIC POTASSIUM PHOSPHATE, SODIUM CHLORIDE AND DEXTROSE MONOHYDRATE | Baxter Healthcare Company | b283a454-0c20-4fbf-92d3-dae1f3cd3cad | 2020-02-13 | Warnings, Adverse reactions | 660YQ98I10 |
| Sterile Water | WATER | Baxter Healthcare Company | 8bcf5572-49e1-4302-9522-56f57904cb4a | 2019-12-29 | Warnings, Adverse reactions | 059QF0KO0R |
| Renacidin | CITRIC ACID, GLUCONOLACTONE AND MAGNESIUM CARBONATE | United-Guardian, Inc. | 13a9bbba-db21-4cba-991c-5d8afaf2ed74 | 2019-12-17 | Warnings, Adverse reactions | XF417D3PSL |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | e41adb4e-06fb-4141-ba55-50b043f3c9da | 2019-11-19 | XF417D3PSL B22547B95K | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 14445dfd-6041-40cd-a043-3f4da6bcb9c1 | 2019-11-18 | XF417D3PSL B22547B95K | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 2557199a-5f60-49d8-b093-1e0700211243 | 2019-11-18 | XF417D3PSL B22547B95K | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 794f724c-87f0-49c1-9b26-c9e491978313 | 2019-11-18 | XF417D3PSL B22547B95K |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.